Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CSX CORP Regulatory Filings 2017

May 19, 2017

29952_rns_2017-05-19_b95de5be-8ee5-4008-9e67-3e0248a7ddac.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

DEFA14A 1 d351789ddefa14a.htm DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒ Filed by a party other than the Registrant ☐

Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

CSX Corporation

(Name of registrant as specified in its charter)

(Name of person(s) filing proxy statement, if other than the Registrant)

Payment of filing fee (Check the appropriate box):

No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by Registration Statement
number, or the Form or Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule, or Registration Statement No:
(3) Filing party:
(4) Date filed:

On Friday, May 19, 2017, CSX filed a Form 8-K that included the following text:

On May 17, 2017, the Wall Street Journal published a story related to the health of E. Hunter Harrison, Chief Executive Officer and President of CSX Corporation. In an interview, Mr. Harrison told the Wall Street Journal, “I’m having a ball and I’m running on so much adrenaline that no one can stop me.” He also said, “Don’t judge me by my medical record, judge me by my performance.” Further, Mr. Harrison said, “There are times when I get a little shortness of breath so I take oxygen and it helps. Sometimes I get a cough and the oxygen makes it go away.”

CSX said “In the absence of performance questions, as a matter of policy we do not comment on health related matters of any CSX executive.” CSX further said Mr. Harrison “has been and continues to be actively and deeply involved on a daily basis.”